ArticleBreathe (Sheffield, England)2021

Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?

Lauren A Quinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.